期刊文献+

2型糖尿病70例临床治疗分析

Clinical treatment analysis of 70 cases with type 2 diabetes
下载PDF
导出
摘要 目的:探讨2型糖尿病的临床治疗方法。方法:2010年2月-2013年4月收治2型糖尿病患者70例,采用数字单双号的模式将其随机分成对照组与治疗组,每组35例。对照组单用二甲双胍缓释片进行治疗,治疗组采用二甲双胍缓释片联合甘精胰岛素进行治疗。结果:治疗后,治疗组23例患者情况为理想,11例患者情况为良好,仅有1例患者无效,总有效率97.14%;对照组中15例患者情况为理想,12例患者情况为良好,8例患者无效,总有效率77.14%。治疗组的总有效率明显高于对照组,差异具有统计学意义(P<0.05)。结论:2型糖尿病患者在口服降糖药的基础上,每天睡前注射一次长效胰岛素,能够有效控制空腹血糖,治疗效果较为理想,值得临床推广运用。 Objective:To explore the clinical treatment of type 2 diabetes.Methods:70 cases with type 2 diabetes were selected from February 2010 to April 2013.They were randomly divided into the control group and the treatment group by using digital single and double mode.Each group had 35 cases.The control group were treated with metformin sustained-release tablets.The treatment group were treated with metformin sustained-release tablets combined with insulin glargine.Results:After treatment,in the treatment group, 23 cases were ideal,11 cases were good,only 1 case was ineffective,and the total effective rate was 97.14%.In the control group, 15 cases were ideal,12 cases were good,8 cases were ineffective,and the total effective rate was 77.14%.The total effective rate of the treatment group was apparently higher than that of the control group.The difference was statistically significant(P<0.05).Conclusion:For the patients with type 2 diabetes,on the basis of the oral medications,long-acting insulin is injected before going to bed every day,which can effectively control the fasting glucose.Its treatment effect is ideal,so it is worthy of clinical application.
作者 余光
出处 《中国社区医师(医学专业)》 2014年第16期31-32,共2页
关键词 2型糖尿病 临床治疗 甘精胰岛素 二甲双胍缓释片 Type 2 diabetes Clinical treatment Insulin glargine Metformin sustained-release tablet
  • 相关文献

参考文献4

二级参考文献23

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2张林霞.糖尿病并发低血糖症58例临床分析[J].医药世界,2007(2):59-60. 被引量:1
  • 3蔡乐,朱珠,王强,刘新月.胰岛素类似物与新型降糖激素类药物[J].中国新药杂志,2007,16(6):432-437. 被引量:26
  • 4kirpichnikov D, MCFarlane SI, Sowers JR. Metformin: an update. Ann Intern Med,2002,137:25-33.
  • 5O'Moore-Sullivan TM, prins JB. Thiazolidinediones and trpe 2 diabetes: new drugs for an old disease. Med J Aust, 2002, 176: 381-386.
  • 6Chilcott J, Tappenden P, Jones ML, et al. A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus Clin Ther,2001,29 : 1792-1823.
  • 7Hermansen K, Davies M, Derezinski T. A 26-week randomized, parallel,treat-to-target trial comparing insulin detmnir with NPH insulin as add-on therapy to oral glucose-lowering druge in insulin- naive people with type 2 diabetes [ J ]. Diabetes Care, 2006,29 (6) :1269-1274.
  • 8Rosenstock J, Davies M, Home P D. A randomized,52-week, treat- to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes [ J ]. Diabetologia, 2008,51 ( 3 ) : 408- 416.
  • 9Hordem S V,Wright J E, Umpteby A M. Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin det- emir and NPH insulin with a 16-h euglycaemic clamp[J]. Diabeto- logia ,2005,48 ( 3 ) :420-426.
  • 10Klein O. Albumin-bound basal insulin analogues ( insulin detemir and NN344) : comparable time-action profile but less variability than insulin glargine in type 2 diabetes[J].Diabetes Obes Metab, 2007,9 ( 3 ) :290-299.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部